Prices have been increased by 5 to 10 percent for 24 different types of drugs manufactured by Libra Infusion.
Sources at the Directorate General of Drug Administration (DGDA) said in light of the current dollar crisis and the rise in raw material prices on the world market, the government has decided to increase the prices of the drugs.
Despite the company's request for a higher price, the drug authority raised the price by about 5 to 10 percent.
Libra infusion price has been increased for 23 products while one remains unchanged. Most of the price increase has been up to 10 per cent while only one product has increased by 14 per cent, said Ayub Hossain.
According to the DGDA official, all other companies that manufacture the same products can also raise the price of their respective products with the approval of the drug authority.
According to DGDA sources, Libra Infusion manufactures 24 types of drugs including IV fluids, none of which are manufactured by any other pharmaceutical company in the country.
The Bangladesh Association of Pharmaceutical Industry (BAPI) has also blamed the rise in raw material prices and dollar crisis for raising drug prices.
Cholera saline 2000 ml was Tk 113, now it's Tk 122, Hartmann's solution 500 ml is now Tk 82, Hartmann's solution 1000 ml is now Tk 105, Hartmann Plus was Tk 55, now Tk 66, Hartmann 1000 ml was Tk 71, now it's Tk 80.
The gradual increase in the prices of medicines will affect the medical care of the country's citizens, according to health experts.
Consumers, especially the poor, will feel the pain of the increase in drug prices as inflation rises in the country, they said.
Earlier this year, the DGDA increased prices of 53 essential drug brands and 20 generics used in primary care after seven years.